| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |